Key result
Suture-mediated closure devices linked to ~4-hour shorter stay vs manual compression in AF ablation.
Why the study?
The rising prevalence of atrial fibrillation has increased pulmonary vein isolations, necessitating optimisation of care pathway efficiency after catheter ablation.
Does the use of suture-mediated vascular closure devices improve hospitalisation duration and patient experience compared to manual compression in patients undergoing catheter ablation for atrial fibrillation?
Observational (n=159)
No
Does the use of suture-mediated vascular closure devices improve hospitalisation duration and patient experience compared to manual compression in patients undergoing catheter ablation for atrial fibrillation?
The use of vascular closure devices after atrial fibrillation ablation significantly reduces hospital stay and improves patient comfort without increasing costs or complications.
Answers are grounded in this paper and cite their sources.
May support expedited discharge after AF ablation; leaves open confirmation in randomized trials.
BACKGROUND: The rising prevalence of atrial fibrillation has led to increasing the numbers of pulmonary vein isolations. Optimising care pathway efficiency is essential for sustainable healthcare delivery. This study aimed to evaluate the impact of closure devices (CD) within the care pathway on hospital stay, patient satisfaction, staff workload, and costs, following catheter ablation for atrial fibrillation. METHODS: This study compared the standard care pathway following catheter ablation using manual compression (MC, December 2023-February 2024) to a modified pathway incorporating suture-mediated CD (March-May 2024). Primary outcomes included process indicators (e.g., hospitalisation duration), clinical outcomes (e.g., bleeding complications), and patient experience. Secondary outcomes included staff experience and healthcare costs associated with procedural changes. RESULTS: A total of 159 patients participated (MC: 81 patients, CD: 78 patients). Patients received an average of 2 percutaneous sutures. Treatment with CDs resulted in a 3.7-hour reduction in hospitalisation duration (p <. 001), 10-minute shorter procedure time in first-time ablations (p = .006), and 4‑hour shorter bed rest (p <. 001). Patients experienced less pain, measured using the Numeric Rating Scale (median 3 vs 1, p = .001), and used less pain medication (p = .006). Discharge comfort was higher in the CD group (p = .009), while complication rates remained similar. 24 nurses participated in the questionnaire. Most nurses reported improved time efficiency and workday organisation. Costs were similar across groups. CONCLUSION: CDs improve care pathways after atrial fibrillation ablation by reducing hospitalisation time, enhancing patient comfort, and improving workflow efficiency without increasing complications.
No takes yet. Share an insight, caveat, or question.
Scheurwater et al. (2026) conducted an observational in Atrial fibrillation (n=159). Suture-mediated closure devices (Perclose ProGlide) vs. Manual compression was evaluated on Hospitalisation duration (hours) (3.7-hour reduction, p=<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: